Samsung to supply Tesla with AI chips
Digest more
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Among high achievers are biopharmaceutical contract manufacturers in South Korea -- Samsung Biologics and Celltrion, both with strong first-half results.
South Korea's top court has upheld an appeals court ruling to dismiss all charges in a long-running fraud case against Samsung chairman Jay Y. Lee. The accounting fraud and stock manipulation charges stemmed from a merger of two Samsung subsidiaries in 2015.
The agreement that Japan secured has added pressure on South Korea to defuse the threat of high tariffs on its exports to the United States.
South Korea's Supreme Court on Thursday upheld the acquittal of Samsung Electronics Chairman Lee Jae-yong on fraud charges after years of legal proceedings.